These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24260802)

  • 1. Part-time vs. full-time occlusion for amblyopia: evidence for part-time patching.
    Matta NS; Silbert DI
    Am Orthopt J; 2013; 63():14-8. PubMed ID: 24260802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of occlusion amblyopia after prescribed full-time occlusion on long-term visual acuity outcomes.
    Longmuir S; Pfeifer W; Scott W; Olson R
    J Pediatr Ophthalmol Strabismus; 2013; 50(2):94-101. PubMed ID: 23205770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical translation of recommendations from randomized clinical trials on patching regimen for amblyopia.
    Jin YP; Chow AH; Colpa L; Wong AM
    Ophthalmology; 2013 Apr; 120(4):657-62. PubMed ID: 23395531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A special role for binocular visual input during development and as a component of occlusion therapy for treatment of amblyopia.
    Mitchell DE
    Restor Neurol Neurosci; 2008; 26(4-5):425-34. PubMed ID: 18997317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized evaluation of spectacles plus alternate-day occlusion to treat amblyopia.
    Agervi P; Kugelberg U; Kugelberg M; Simonsson G; Fornander M; Zetterström C
    Ophthalmology; 2010 Feb; 117(2):381-7. PubMed ID: 20006908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of split hours part-time patching versus continuous hours part-time patching for treatment of anisometropic amblyopia in children: a pilot study.
    Sachdeva V; Mittal V; Kekunnaya R; Gupta A; Rao HL; Mollah J; Sontha A; Gunturu R; Rao BV
    Br J Ophthalmol; 2013 Jul; 97(7):874-8. PubMed ID: 23677988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patching compliance with full-time vs. part-time occlusion therapy.
    Kane J; Biernacki R; Fraine L; Fukuda N; Haskins K; Morrison DG
    Am Orthopt J; 2013; 63():19-23. PubMed ID: 24260803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance.
    Awan M; Proudlock FA; Gottlob I
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1435-9. PubMed ID: 15790912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect and sustainability of part-time occlusion therapy for patients with anisometropic amblyopia aged > or =8 years.
    Hwang DJ; Kim YJ; Lee JY
    Br J Ophthalmol; 2010 Sep; 94(9):1160-4. PubMed ID: 20530177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of electronically monitored amblyopia treatment between 5 and 16 years of age: new insight into declining susceptibility of the visual system.
    Fronius M; Cirina L; Ackermann H; Kohnen T; Diehl CM
    Vision Res; 2014 Oct; 103():11-9. PubMed ID: 25130409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patching regimens for amblyopia.
    Kushner BJ
    Ophthalmology; 2005 Apr; 112(4):736-7; author reply 737. PubMed ID: 15808278
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term effectiveness of different regimens of occlusion on recovery from early monocular deprivation in kittens.
    Mitchell DE
    Philos Trans R Soc Lond B Biol Sci; 1991 Jul; 333(1266):51-79. PubMed ID: 1682958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of amblyopia therapy initiated after 9 years of age.
    Park KH; Hwang JM; Ahn JK
    Eye (Lond); 2004 Jun; 18(6):571-4. PubMed ID: 15184922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occlusion therapy of unilateral amblyopia with botulinum toxin induced ptosis.
    Halkiadakis I; Iliaki O; Kalyvianaki MI; Tsilimbaris MK
    Semin Ophthalmol; 2007; 22(1):55-7. PubMed ID: 17366121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor.
    Fronius M; Chopovska Y; Nolden J; Loudon SE; Lüchtenberg M; Zubcov A; Pepler L
    Strabismus; 2006 Jun; 14(2):65-70. PubMed ID: 16760110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of 3 hours part-time occlusion treatment combined with near activities among children with unilateral amblyopia.
    Alotaibi AG; Fawazi SM; Alenazy BR; Abu-Amero KK
    Saudi Med J; 2012 Apr; 33(4):395-8. PubMed ID: 22485234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of visual acuity in a historical cohort of 137 patients treated for amblyopia by occlusion 30-35 years ago].
    Simonsz-Tóth B; Loudon SE; van Kempen-du Saar H; van de Graaf ES; Groenewoud JH; Simonsz HJ
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):40-6. PubMed ID: 17260318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-time occlusion compared to part-time occlusion for the treatment of amblyopia.
    Hug T
    Optometry; 2004 Apr; 75(4):241-4. PubMed ID: 15117057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of occlusion on the visual evoked response in amblyopia.
    Arden GB; Barnard WM
    Trans Ophthalmol Soc U K (1962); 1979; 99(3):419-26. PubMed ID: 298825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.